Results for tag: "Antibody Combination Therapy"

The Antibody Combination Therapy market within the context of Oncology Drugs is a rapidly growing field of research and development. This type of therapy combines two or more antibodies to target cancer cells, with the aim of improving the efficacy of treatment. It is believed that this type of therapy can be used to treat a variety of cancers, including breast, lung, and colorectal cancer. The use of antibody combination therapy has the potential to reduce the side effects associated with traditional chemotherapy and radiation treatments. The market for antibody combination therapy is expected to grow significantly in the coming years, as more research is conducted and new treatments are developed. This growth is driven by the increasing prevalence of cancer, as well as the need for more effective treatments. Some of the major players in the Antibody Combination Therapy market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more